Subtopic Deep Dive

Acanthosis Nigricans in Diabetes
Research Guide

What is Acanthosis Nigricans in Diabetes?

Acanthosis nigricans is a dermatological condition characterized by hyperpigmented, velvety plaques primarily in skin folds, serving as a cutaneous marker of insulin resistance in type 2 diabetes and obesity.

Acanthosis nigricans associates with hyperinsulinemia and glucose intolerance, as shown in six patients with insulin receptor defects on monocytes (Kahn et al., 1976, 1101 citations). Prevalence reaches significant levels in unselected populations, linking to metabolic disorders (Stuart et al., 1989, 179 citations). Over 10 papers from 1976-2013 detail its pathogenesis and ties to syndromes like polycystic ovary syndrome.

15
Curated Papers
3
Key Challenges

Why It Matters

Acanthosis nigricans predicts type 2 diabetes risk, enabling early screening in obese patients (Hermanns-Lé et al., 2004). It identifies insulin-resistant states distinct from type A/B syndromes in hyperandrogenic women (Flier et al., 1985). Clinicians use it for metabolic syndrome management; dermatologists recognize paraneoplastic forms (da Silva et al., 2013). García Hidalgo (2002) links it to obesity complications, guiding weight loss therapies.

Key Research Challenges

Pathogenic Mechanisms

Linking hyperinsulinemia to epidermal hyperplasia remains unclear despite receptor studies (Kahn et al., 1976). Growth factors like tyrosine kinases show indirect roles (Torley et al., 2002). Genetic disorders complicate causal models (Torley et al., 2002).

Diagnostic Criteria

Standardizing AN severity scores for diabetes risk lacks consensus (Schwartz, 1994). Prevalence varies by population, hindering screening thresholds (Stuart et al., 1989). Overlap with paraneoplastic forms confuses differentiation (da Silva et al., 2013).

Therapeutic Targets

Treating underlying insulin resistance yields inconsistent AN resolution (Hermanns-Lé et al., 2004). Syndromic variants resist standard interventions (Kahn et al., 1976). Obesity-related cases demand multimodal approaches (García Hidalgo, 2002).

Essential Papers

1.

The Syndromes of Insulin Resistance and Acanthosis Nigricans

C. Ronald Kahn, Jeffrey S. Flier, Robert S. Bar et al. · 1976 · New England Journal of Medicine · 1.1K citations

In six patients with acanthosis nigricans variable degrees of glucose intolerance, hyperinsulinemia and marked resistance to exogenous insulin were found. Studies of insulin receptors on circulatin...

2.

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

Edward E. Wallach, Robert L. Barbieri, Samuel Smith et al. · 1988 · Fertility and Sterility · 357 citations

3.

Acanthosis nigricans

Robert A. Schwartz · 1994 · Journal of the American Academy of Dermatology · 279 citations

4.

Dermatological Complications of Obesity

Linda Garc a Hidalgo · 2002 · American Journal of Clinical Dermatology · 211 citations

5.

Insulin resistance in polycystic ovary syndrome

Donna Shoupe, Dinesh D. Kumar, Rogerio A. Løbo · 1983 · American Journal of Obstetrics and Gynecology · 197 citations

6.

Prevalence of acanthosis nigricans in an unselected population

Charles Stuart, Claudia J. Pate, Edward J. Peters · 1989 · The American Journal of Medicine · 179 citations

7.

Paraneoplastic cutaneous manifestations: concepts and updates*

Josenilson Antônio da Silva, Kleyton de Carvalho Mesquita, Ana Carolina de Souza Machado Igreja et al. · 2013 · Anais Brasileiros de Dermatologia · 179 citations

The skin often signals systemic changes. Some neoplastic diseases that affect internal organs may trigger several cutaneous manifestations. Although these dermatoses are relatively unusual, the rec...

Reading Guide

Foundational Papers

Start with Kahn et al. (1976) for insulin resistance syndromes and receptor biology; Flier et al. (1985) for obesity-hyperandrogenism distinctions; Schwartz (1994) for clinical overview.

Recent Advances

Hermanns-Lé et al. (2004) on insulin resistance associations; Torley et al. (2002) on genetic/growth factors; da Silva et al. (2013) for paraneoplastic updates.

Core Methods

Monocyte insulin binding assays (Kahn 1976); population prevalence studies (Stuart 1989); tyrosine kinase pathway analysis (Torley 2002); hyperinsulinemia models in PCOS (Barbieri 1988).

How PapersFlow Helps You Research Acanthosis Nigricans in Diabetes

Discover & Search

Research Agent uses searchPapers and citationGraph to map Kahn et al. (1976) as the foundational hub with 1101 citations, revealing clusters on insulin resistance syndromes; exaSearch uncovers prevalence data from Stuart et al. (1989); findSimilarPapers extends to obesity links in García Hidalgo (2002).

Analyze & Verify

Analysis Agent applies readPaperContent to extract monocyte insulin receptor data from Kahn et al. (1976), verifies hyperinsulinemia claims via verifyResponse (CoVe), and runs PythonAnalysis for statistical correlation of AN prevalence with glucose intolerance using NumPy/pandas on datasets from Stuart et al. (1989); GRADE grading scores evidence strength for diagnostic utility.

Synthesize & Write

Synthesis Agent detects gaps in genetic AN therapies post-Torley et al. (2002) and flags contradictions between benign and paraneoplastic forms (da Silva et al., 2013); Writing Agent uses latexEditText, latexSyncCitations for Kahn (1976), and latexCompile to generate review manuscripts with exportMermaid diagrams of pathogenesis pathways.

Use Cases

"Correlate AN prevalence rates with BMI in diabetic cohorts using stats."

Research Agent → searchPapers (Stuart 1989) → Analysis Agent → runPythonAnalysis (pandas regression on prevalence/BMI data) → matplotlib plot of correlations exported as figure.

"Draft LaTeX review on AN as diabetes predictor citing Kahn 1976."

Synthesis Agent → gap detection → Writing Agent → latexEditText (structure sections) → latexSyncCitations (Kahn/Flier) → latexCompile → PDF with inline citations.

"Find code for analyzing insulin receptor binding in AN studies."

Research Agent → paperExtractUrls (Kahn 1976 supplements) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for receptor kinetics modeling.

Automated Workflows

Deep Research workflow scans 50+ papers via citationGraph from Kahn (1976), producing structured reports on AN-diabetes links with GRADE scores. DeepScan applies 7-step CoVe to verify pathogenesis claims from Flier (1985), checkpointing statistical analyses. Theorizer generates hypotheses on growth factor roles by synthesizing Torley (2002) with hyperandrogenism data (Barbieri 1988).

Frequently Asked Questions

What defines acanthosis nigricans in diabetes?

Hyperpigmented velvety plaques in flexures mark insulin resistance; Kahn et al. (1976) link it to hyperinsulinemia and monocyte receptor defects.

What are key methods studying AN pathogenesis?

Insulin receptor assays on monocytes (Kahn et al., 1976); prevalence surveys (Stuart et al., 1989); growth factor tyrosine kinase analysis (Torley et al., 2002).

What are seminal papers on AN and insulin resistance?

Kahn et al. (1976, 1101 citations) defines syndromes; Flier et al. (1985) characterizes obesity-hyperandrogenism state; Hermanns-Lé et al. (2004) reviews associations.

What open problems exist in AN research?

Standardized diagnostic scoring (Schwartz, 1994); resolving paraneoplastic vs. metabolic forms (da Silva et al., 2013); targeted therapies beyond insulin sensitization (García Hidalgo, 2002).

Research Skin Diseases and Diabetes with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Acanthosis Nigricans in Diabetes with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers